Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment

on behalf of the TARGIT-A trial authors

Research output: Contribution to journalComment/debatepeer-review

9 Citations (Scopus)

Abstract

In the randomised TARGIT-A trial, risk-adapted targeted intraoperative radiotherapy (TARGIT-IORT) during lumpectomy was non-inferior to whole-breast external beam radiotherapy, for local recurrence. In the long-term, no difference was found in any breast cancer outcome, whereas there were fewer deaths from non-breast-cancer causes. TARGIT-IORT should be included in pre-operative consultations with eligible patients.

Original languageEnglish
Pages (from-to)1469-1474
Number of pages6
JournalBritish Journal of Cancer
Volume124
Issue number9
DOIs
Publication statusPublished - 27 Apr 2021

Fingerprint

Dive into the research topics of 'Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment'. Together they form a unique fingerprint.

Cite this